|
|
Radiation Therapy Svcs (RTSX)This is an EDITABLE stock research wiki. You can contribute by clicking on the EDIT PAGE link above or on the page icons that appear when you roll over one of the category subtitles below. From 1Table of contents
Company Information:Company Address: 2234 Colonial Boulevard Fort Myers, FL 33907
Company’s Web Address: http://rtsx.client.shareholder.com/
Industry Sector:
Fiscal Year: Dividend:
Note: this section is not editable.
Please click here to report any inaccuracies.
Company Overview:Note: this section is not editable.
Radiation Therapy Services, Inc (RTSX), based in Fort Myers, Florida, provides radiation therapy services to cancer patients in 27 local markets across 16 states. Founded in 1983 and floated in 2004, the company currently operates 83 treatment centers, both freestanding and hospital-based, and offers a range of radiation therapy services through its wholly owned subsidiary, 21st Century Oncology, Inc. The company's current suite of treatments include: conventional external beam radiation therapy, intensity modulated radiation therapy, respiratory gating, 3-D conformal treatment planning, stereotactic radiosurgery, and high/low dose rate brachytherapy. The company receives payments for services rendered to patients from Medicare and Medicaid programs, commercial insurers, managed care organizations and patients directly. The reimbursement for radiation therapy services includes a professional component for the physician's service and a technical component to cover the costs of the machine, facility and services provided by the technical staff. In the freestanding centers the company provides both services while in a hospital-based center the hospital, rather than RTSX, provides the technical services. Generally, revenue is determined by a number of factors, including the payor mix, the number and nature of procedures performed and the rate of payment for the procedures. The average revenue per treatment is sensitive to the mix of services used in treating a patient's tumor and typically higher for the more advanced treatment technologies. In FY06, RTSX reported total revenue of $294M, up 29% y/y, consisting of revenue generated from services billed to patients directly, principally at freestanding treatment centers, of $284.1M, and revenue generated principally from services billed to hospitals for services provided, of $9.9M. The company has grown primarily by acquisition, strategic alliances and joint ventures. In 2006 RTSX entered 2 new local markets and acquired 11 treatment centers. To date RTSX has entered 12 local markets through acquisitions and acquired 44 treatment centers. On October 19, 2007, RTSX entered into an agreement to be purchased by Vestar Capital for $32.50 per share plus assumed debt, for a deal valued at $1.1B. The Board of Directors of Radiation Therapy Services has approved the merger agreement on the unanimous recommendation of a Special Committee of independent directors and recommends that Radiation Therapy Services' shareholders adopt the agreement. The transaction is expected to close in 1Q08.
Valuation:Enter Valuation Analysis and Valuation Ratios Here
Projected Financials:Income Statement: (Paste Here) Balance Sheet: (Paste Here) Cash Flow Statement: (Paste Here) Financial Ratios: (Paste Here) Other: (Paste Here)
Tags:
none
The opinions and views expressed in this document do not necessarily reflect the views or opinions of InvestingMinds. InvestingMinds did not prepare and does not endorse such content. Please note that it is intended for general circulation only and the recommendations contained herein do not take into account the specific investment objectives, financial situation or particular needs of any particular person. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy securities or other instruments. No part of this document may be reproduced in any manner without the written permission of InvestingMinds.
|
||||||||||||||||||||||||
|
|